外科用被覆材の世界市場：2023～2030年

世界の外科用被覆材市場は予測期間（2023～2030年）にCAGR 6.4％で成長すると予測されています。静脈性下腿潰瘍、褥瘡、糖尿病性足潰瘍などの慢性創傷の蔓延により、創傷ケアの専門家に対する課題が増加しており、外科用被覆材材産業の成長に大きな影響を与えています。米国疾病予防管理センター（CDC）によると、3,700万人以上の米国人が糖尿病を患っており、さらに9,600万人の米国人成人が2型糖尿病のリスクがある糖尿病予備軍と呼ばれる状態にあります。糖尿病患者の約25％は傷の治りが悪く、下肢の切断につながりかねず、経済的にも心理的にも大きな影響を及ぼします。高血糖環境はバイオフィルムの増殖を促し、糖尿病創傷の治療を困難にしています。糖尿病は、心臓病、腎不全、失明などの深刻な合併症を引き起こす可能性があります。2022年10月、オーストラリア保健・高齢者介護省が発表した報告書によると、同省は創傷管理のために2019年から2021年までの3年間で120万米ドルを目標投資しました。慢性創傷はオーストラリアでは重大な問題であり、病院や住宅介護の現場では年間40万件の症例があると推定されています。

さらに、国立衛生研究所（NIH）によると、治癒しない慢性創傷（CNHW）は一般的に糖尿病、血管障害、高血圧、慢性腎臓病などの併存疾患と相関しています。その結果、外科用被覆材の需要が増加しています。さらに、食品医薬品局（FDA）の認可数が増加していることも、外科用被覆材の採用が増加している要因となっています。2023年4月、3M医療の革新的な3M（TM）Veraflo（TM）Therapyは、3M（TM）Veraflo（TM）Cleanse Choice Complete（TM）Dressingと3M（TM）V.A.C.の両方を備えています。Veraflo Cleanse Choice（TM）被覆材は、感染性物質、非生存組織、創傷残屑を水圧機械的に除去し、外科的デブリードメントの回数を減らすと同時に、肉芽組織の形成を促進し、創傷治癒を促進する環境を作り出すという、初めての食品医薬品局（FDA）の認可を受けた。

セグメント別展望

外科用被覆材の世界市場では、病院が大きなシェアを占めると予想されます。

エンドユーザーの中でも、病院のサブセグメントが世界の外科用被覆材市場でかなりのシェアを占めると予想されています。このセグメントの成長は、外科外科の増加、糖尿病性足潰瘍の増加、病院数の増加に起因しています。病院は、選択的外科を含む入院患者ケア、救急部門ケア、外来患者（非入院患者）ケアなどのサービスを提供しています。米国病院協会（AH）の最新調査によると、米国の病院総数は2023年に6,129となります。さらに、オーストラリア保健福祉研究所によると、オーストラリアでは入院患者数が増加しています。2021～22年の入院患者数は1,160万人で、患者治療日数は3,180万日、入院の59.0％（680万人）は公立病院で、患者治療日数（2,170万日）の68.0％を占めています。一方、私立病院での入院は41.0％（480万人）で、入院日数（1,000万日）に占める割合は32.0％でした。このように、病院数と入院患者数の増加に伴い、このセグメントは予測期間中に大きく成長すると予測されます。

地域別展望

世界の外科用被覆材市場はさらに、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他の欧州地域）、アジア太平洋（インド、中国、日本、韓国、その他アジア地域）、世界のその他の中東・アフリカ（中東およびアフリカ、ラテンアメリカ）を含む地域別に区分されます。なかでも欧州は、糖尿病有病率の増加、研究開発の増加、医療ツーリズム産業の成長により、全世界で突出した市場シェアを占めると予想されます。

アジア太平洋は世界の外科用被覆材市場で大きなCAGRで成長する見込み

すべての地域の中で、アジア太平洋は予測期間中にかなりのCAGRで成長すると予測されています。アジア太平洋の外科用被覆材市場は中国が支配的で、インド、日本、韓国、その他のアジア太平洋がこれに続く。中国の外科用被覆材市場は、外科件数の増加、心血管疾患関連の外科件数の増加、糖尿病などの慢性疾患の有病率の増加によって成長を遂げています。世界保健機関（WHO）によると、中国の糖尿病患者数は世界で最も多く、2019年には約1億1,600万人の有効患者がおり、2040年には1億5,000万人に増加すると予測されています。2009年の推定糖尿病有病率は3.9％で、2030年には5.4％に増加すると予測されています。中国の20～79歳の成人における糖尿病有病率は、2020～2030年に8.2％から9.7％に増加すると予測されています。Winner Medical、Covalonなど中国の参入企業による創傷ケア管理分野の拡大と台頭が市場の成長に寄与しています。例えば、2022年6月、Winner MedicalはEWMA 2022会議で、最新かつ業界をリードする高度創傷ケアソリューションを展示しました。同会議でWinner Medicalは、透明フィルム被覆材、SAF付きボーダーシリコンフォーム被覆材、抗菌シリーズ製品、新製品であるCMC被覆材などの新製品も発表しました。Winner Medicalの創傷ケア製品は、糖尿病、不動、静脈疾患、外傷、火傷、侵襲的外科などに起因する急性および慢性の創傷に対する創傷管理を提供する主要なソリューションとして、110カ国以上で広く使用されています。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリスト洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• 3M Co.
• ConvaTec Group Plc
• Johnson & Johnson Services, Inc.
• Smith & Nephew Plc
• 主要戦略分析

第4章 市場セグメンテーション

• 外科用被覆材の世界市場：タイプ別
  • コラーゲン被覆材
  • 透明フィルム被覆材
  • アルジネート被覆材
  • 発泡被覆材
  • ガーゼ被覆材
  • シルバー被覆材
  • その他（ハイドロゲル被覆材、コンポジット被覆材）
• 外科用被覆材の世界市場：用途別
  • 心血管疾患（CVD）
  • 糖尿病に基づく外科
  • 移植部位
  • 潰瘍
  • 火傷
• 外科用被覆材の世界市場：エンドユーザー別
  • 病院
  • 外来外科センター
  • 専門クリニック
  • 在宅医療

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• 世界のその他の中東・アフリカ

第6章 企業プロファイル

• Abigo Medical AB
• B. Braun SE
• Baxter Healthcare Corp.
• Cardinal Health Inc.
• Coloplast A/S
• ConvaTec Group Plc
• Derma Sciences Inc.（Integra LifeSciences）
• Essity Aktiebolag AB,
• Medline Industries Inc.
• Medtronic Plc
• Molnlycke Health Care AB
• Molnlycke Health Care AB
• Narang Medical Ltd
• Organogenesis Holdings Inc.
• Sanara MedTech, Inc.

LIST OF TABLES

• 1. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 2. GLOBAL COLLAGEN DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 3. GLOBAL TRANSPARENT FILM DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL ALGINATE DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 5. GLOBAL FOAM DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 6. GLOBAL GAUZE DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 7. GLOBAL SILVER DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 8. GLOBAL OTHER TYPES OF SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 9. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLIACTION, 2022-2030 ($ MILLION)
• 10. GLOBAL SURGICAL DRESSING FOR CARDIOVASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 11. GLOBAL SURGICAL DRESSING FOR DIABETES BASED SURGERIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 12. GLOBAL SURGICAL DRESSING FOR TRANSPLANT SITES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 13. GLOBAL SURGICAL DRESSING FOR ULCERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 14. GLOBAL SURGICAL DRESSING FOR BURNS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 15. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 16. GLOBAL SURGICAL DRESSING IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 17. GLOBAL SURGICAL DRESSING IN AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 18. GLOBAL SURGICAL DRESSING IN SPECIALTY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 19. GLOBAL SURGICAL DRESSING IN HOME HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 20. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 21. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 22. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 23. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 24. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 25. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 26. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 27. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 28. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 29. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 30. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 31. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 32. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 33. REST OF THE WORLD SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
• 34. REST OF THE WORLD SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 35. REST OF THE WORLD SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL SURGICAL DRESSING MARKET SHARE BY TYPE, 2022 VS 2030 (%)
• 2. GLOBAL COLLAGEN DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL TRANSPARENT FILM DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL ALGINATE DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL FOAM DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 6. GLOBAL GAUZE DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 7. GLOBAL SILVER DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 8. GLOBAL OTHER TYPES OF SURGICAL DRESSING MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL SURGICAL DRESSING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
• 10. GLOBAL SURGICAL DRESSING FOR CARDIOVASCULAR DISEASES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 11. GLOBAL SURGICAL DRESSING FOR DIABETES BASED SURGERIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 12. GLOBAL SURGICAL DRESSING FOR TRANSPLANT SITES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 13. GLOBAL SURGICAL DRESSING FOR ULCERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 14. GLOBAL SURGICAL DRESSING FOR BURNS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 15. GLOBAL SURGICAL DRESSING MARKET SHARE BY END-USER, 2022 VS 2030 (%)
• 16. GLOBAL SURGICAL DRESSING IN HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 17. GLOBAL SURGICAL DRESSING IN AMBULATORY SURGICAL CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 18. GLOBAL SURGICAL DRESSING IN SPECIALTY CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 19. GLOBAL SURGICAL DRESSING IN HOME HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 20. GLOBAL SURGICAL DRESSING MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 21. US SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 22. CANADA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 23. UK SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 24. FRANCE SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 25. GERMANY SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 26. ITALY SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 27. SPAIN SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 28. REST OF EUROPE SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 29. INDIA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 30. CHINA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 31. JAPAN SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 32. SOUTH KOREA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 33. REST OF ASIA-PACIFIC SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
• 34. REST OF THE WORLD SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)

Title: Global Surgical Dressing Market Size, Share & Trends Analysis Report by Type (Collagen Dressings, Transparent Film Dressings, Alginate Dressings, Foam Dressings, Gauze Dressings, Silver Dressings, and Others), by Application (Cardiovascular Diseases (CVD), Diabetes Based Surgeries, Transplant Sites, Ulcers, and Burns), and by End-User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Home Healthcare)Forecast Period (2023-2030).

The global surgical dressing market is anticipated to grow at a CAGR of 6.4% during the Forecast Period (2023-2030). The prevalence of chronic wounds, such as venous leg ulcers, pressure ulcers, and diabetic foot ulcers, is increasing challenges to wound care professionals, having a considerable impact on the growth of the surgical dressing industry. According to the Centers for Disease Control and Prevention (CDC), more than 37 million Americans have diabetes, and another 96 million adults in the US have a condition called prediabetes, which puts them at risk for type 2 diabetes. About 25% of individuals with diabetes mellitus have poor wound healing, which can lead to the removal of lower limbs and has significant financial and psychological consequences. The hyperglycemic environment encourages the growth of biofilms and makes it challenging to treat diabetic wounds. Diabetes can cause serious complications, including heart disease, kidney failure, and blindness. In October 2022, according to the report published by the Australian Department of Health and Aged Care, the department made a targeted investment of $1.20 million over three years from 2019-2021 for wound management. Chronic wounds are a significant problem in Australia, with an estimated 400,000 cases in hospital and residential care settings yearly.

Furthermore, according to the National Institute of Health (NIH), chronic non-healing wounds (CNHW) are typically correlated with comorbidities such as diabetes, vascular deficits, hypertension, and chronic kidney disease. The result has increased the demand for surgical dressing. Furthermore, the rising number of food and drug administration (FDA) clearance also attributed to the increasing adoption of surgical dressing. In April 2023, 3M Health Care's innovative 3M™ Veraflo™ Therapy, with both 3M™ Veraflo™ Cleanse Choice Complete™ Dressing and 3M™ V.A.C. Veraflo Cleanse Choice™ Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridement required, while promoting granulation tissue formation, creating an environment that promotes wound healing.

Segmental Outlook

The global surgical dressing market is segmented on the type, application, and end-user. Based on the type, the market is sub-segmented into collagen dressings, transparent film dressings, alginate dressings, foam dressings, gauze dressings, silver dressings, and others. Further, other types of surgical dressing include hydrogel dressings, composites dressings. Based on the application, the market is sub-segmented into cardiovascular diseases, diabetes-based surgeries, transplant sites, ulcers, and burns. Further, based on the end-user, the market is sub-segmented into hospitals, ambulatory surgery centers, specialty clinics and home healthcare. Among the type, the transparent film dressings sub-segment is anticipated to hold a considerable share of the market, owing to the maintaining wound moisture and reducing infection rates.

The Hospitals Sub-Segment is Anticipated to Hold a Considerable Share of the Global Surgical Dressing Market

Among the end-user, the hospitals sub-segment is expected to hold a considerable share of the global surgical dressing market. The segmental growth is attributed to the growing number of surgical procedures, increasing occurrence of diabetic foot ulcers, and rising number of hospitals. Hospitals provide services such as admitted patient care, including for elective surgery, emergency department care, and outpatient (non-admitted patient) care. As per the latest survey by the American Hospital Association (AH), the total number of hospitals in the US was counted ware 6,129 in 2023. Moreover, according to the Australian Institute of Health and Welfare, the number of hospitalizations in Australia has increased. In In 2021-22, there were 11.6 million hospitalizations, covering 31.8 million days of patient care, 59.0% (6.8 million) of hospitalizations were in public hospitals, accounting for 68.0.% of days of patient care (21.7 million). There are 41.0% (4.8 million) of hospitalizations were in private hospitals, accounting for 32.0% of days of patient care (10.0 million). Thus, with a growing number of hospitals, and hospitalization cases, the segment is projected to grow significantly over the forecast period.

Regional Outlook

The global surgical dressing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the increasing prevalence of diabetes, increasing R&D and growing medical tourism industry.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Surgical Dressing Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. China dominates the Asia-Pacific surgical dressing market followed by India, Japan, South Korea, and the rest of the Asia-Pacific economies. The surgical dressing market in China is experiencing growth owing to rising number of surgeries, rising number of cardiovascular disease-related surgeries, and increasing prevalence of chronic disorders, such as diabetes. According to the World Health Organization, China has the highest number of diabetic patients globally, with nearly 116 million active cases in 2019, and is expected to increase to 150 million by 2040. The estimated diabetes prevalence rate in China in 2009 was 3.9% and is projected to increase to 5.4% by 2030. The prevalence of diabetes in Chinese adults aged 20-79 years is projected to increase from 8.2% to 9.7% during 2020-2030. The expansion and emergence of the wound care management sector by Chinese players such as Winner Medical, Covalon, and others contribute to the market's growth. For instance, in June 2022, Winner Medical displayed its latest and industry-leading advanced wound care solutions at the EWMA 2022 conference. At the conference, Winner Medical also launched a new product such as transparent film dressing, bordered silicone foam dressing with SAF and antibiosis series products and its new product, the CMC dressing. Winner Medical's wound care products have been widely used in more than 110 countries as primary solutions to provide wound management for acute and chronic wounds resulting from diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.

Market Players Outlook

The major companies serving the global surgical dressing market include: 3M Co., ConvaTec Group Plc, Johnson & Johnson Services, Inc., Smith & Nephew Plc, Abigo Medical AB, B. Braun SE, Baxter Healthcare Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2022, Convatec Group Plc, a global medical solutions company focused on the management of chronic conditions, entered into a definitive agreement to acquire Triad Life Sciences Inc., a US-focused medical device company that develops biologically derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global surgical dressing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. 3M Co.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. ConvaTec Group Plc
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Johnson & Johnson Services, Inc.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Smith & Nephew Plc
  • 3.5.1. Overview
  • 3.5.2. Financial Analysis
  • 3.5.3. SWOT Analysis
  • 3.5.4. Recent Developments
• 3.6. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Surgical Dressing Market by Type
  • 4.1.1. Collagen Dressings
  • 4.1.2. Transparent Film Dressings
  • 4.1.3. Alginate Dressings
  • 4.1.4. Foam Dressings
  • 4.1.5. Gauze Dressings
  • 4.1.6. Silver Dressings
  • 4.1.7. Other (Hydrogel Dressings, Composites Dressings)
• 4.2. Global Surgical Dressing Market by Application
  • 4.2.1. Cardiovascular Diseases (CVD)
  • 4.2.2. Diabetes Based Surgeries
  • 4.2.3. Transplant Sites
  • 4.2.4. Ulcers
  • 4.2.5. Burns
• 4.3. Global Surgical Dressing Market by End-User
  • 4.3.1. Hospitals
  • 4.3.2. Ambulatory Surgery Centers
  • 4.3.3. Specialty Clinics
  • 4.3.4. Home Healthcare

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Abigo Medical AB
• 6.2. B. Braun SE
• 6.3. Baxter Healthcare Corp.,
• 6.4. Cardinal Health Inc.
• 6.5. Coloplast A/S
• 6.6. ConvaTec Group Plc
• 6.7. Derma Sciences Inc. (Integra LifeSciences)
• 6.8. Essity Aktiebolag AB,
• 6.9. Medline Industries Inc.
• 6.10. Medtronic Plc
• 6.11. Molnlycke Health Care AB
• 6.12. Molnlycke Health Care AB,
• 6.13. Narang Medical Ltd
• 6.14. Organogenesis Holdings Inc.,
• 6.15. Sanara MedTech, Inc.,